| 1 |
29284646 | A Drug Regimen for Progressive Familial Cholestasis Type 2. | 2018 Jan |
1 |
| 2 |
26223708 | Successful treatment with 4-phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption. | 2016 Feb |
2 |
| 3 |
27757140 | Bipolar and Related Disorders Induced by Sodium 4-Phenylbutyrate in a Male Adolescent with Bile Salt Export Pump Deficiency Disease. | 2016 Sep |
2 |
| 4 |
25716872 | Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate. | 2015 Aug |
6 |
| 5 |
25022842 | Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1. | 2014 Jul 15 |
2 |
| 6 |
25274209 | [Development of new therapeutic strategy for transporter-related diseases]. | 2014 |
2 |
| 7 |
22262466 | AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function. | 2012 Jun |
1 |
| 8 |
22464344 | Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2. | 2012 May 1 |
2 |
| 9 |
22609309 | Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2. | 2012 Sep |
4 |
| 10 |
17538928 | 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. | 2007 Jun |
4 |